Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Super selective intra-arterial cisplatin plus oral S-1 induction chemotherapy for locally advanced oral cancer
jRCTs041220065Phase 2Recruiting
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and tegafur in Oral Mucosal Carcinoma. Primary endpoints: Dose-limiting toxicity rate (Phase I) and Response rate (Phase II). Started Sep 2023; status: recruiting.
02
Drugs
cisplatintegafur
03
Conditions
Oral Mucosal Carcinoma
Beyond the preview
Go deeper on jRCTs041220065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220065.